A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension

Clinical trial NCT03822559 · COMPLETED

Trial details

NCT number: NCT03822559
Sponsor: Santen Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Open-angle Glaucoma, Ocular Hypertension

Start date: 2019-01-20
Primary completion: 2023-04-04
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.